Grtpa and renal failure acute Patient Reports February 12, 2012

Grtpa Side Effects Report #5331698-1
Grtpa side effect was reported by a Physician from JAPAN on May 17, 2007. Male patient, 71 years of age, was diagnosed with cerebral artery embolism and was treated with Grtpa. After drug was administered, patient experienced the following side effects: renal failure acute. Grtpa dosage: 41.4 MG, UNK. During the same period patient was treated with ADALAT, HERBESSER, LACTEC, GLYCERIN, FRUCTOSE, HUMULIN, LASIX, VITAMIN D. Patient died on 01/14/2006.

Grtpa Side Effects Report #5082956-X
Grtpa side effect was reported by a Health Professional from JAPAN on Aug 07, 2006. Male patient, 71 years of age, was diagnosed with cerebral artery embolism and was treated with Grtpa. After drug was administered, patient experienced the following side effects: blood glucose increased, blood pressure increased, cardiac failure, haemorrhagic cerebral infarction, renal failure acute, shock, subarachnoid haemorrhage. Grtpa dosage: 41.4 MG, INTRAVENOUS. During the same period patient was treated with ADALAT, DILTIAZEM HYDROCHLORIDE, LACTEC, GLYCERIN, FRUCTOSE, HUMULIN R, LASIX, VITAMIN D. Patient died on 01/14/2006.

Grtpa Side Effects Report #4971518-8
Grtpa side effect was reported by a Physician from JAPAN on Mar 28, 2006. Male patient, 71 years of age, was diagnosed with cerebral artery embolism and was treated with Grtpa. After drug was administered, patient experienced the following side effects: blood glucose increased, blood pressure increased, haemorrhagic cerebral infarction, renal failure acute, subarachnoid haemorrhage. Grtpa dosage: 41.4 MG, INTRAVENOUS. During the same period patient was treated with ADALAT, DILTIAZEM HYDROCHLORIDE, LACTEC, GLYCERIN, FRUCTOSE, HUMULIN R, LASIX, VITAMIN D. Patient died.

Grtpa Side Effects Report #4974751-4
Grtpa side effect was reported by a Health Professional from JAPAN on Apr 03, 2006. Male patient, 71 years of age, was diagnosed with cerebral artery embolism and was treated with Grtpa. After drug was administered, patient experienced the following side effects: blood glucose increased, blood pressure increased, brain oedema, condition aggravated, haemorrhagic cerebral infarction, renal failure acute, renal impairment, shock, subarachnoid haemorrhage. Grtpa dosage: 41.4 MG, INTRAVENOUS. During the same period patient was treated with ADALAT, DILTIAZEM HYDROCHLORIDE, LACTEC, GLYCERIN, FRUCTOSE, HUMULIN R, LASIX, VITAMIN D. Patient died on 01/14/2006.